The immune environment of paediatric solid malignancies: Evidence from an immunohistochemical study of clinical cases

Fetal and Pediatric Pathology

Volumn 32, Issue 4, 2013, Pages 298-307

  Apps, John R ^a   Hasan, Fyeza ^a   Campus, Oliver ^b   Behjati, Sam ^a   Jacques, Thomas S ^b   J Sebire, Neil ^b   Anderson, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

CD3; CD68; Immune environment; Paediatric cancer; STAT3

Indexed keywords

CD3 ANTIGEN; CHLORDANE; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BONE MARROW CELL; CELL INFILTRATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; RHABDOID TUMOR; SARCOMA; SOLID TUMOR;

CHILD; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MICROENVIRONMENT;

EID: 84879350559     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513815.2012.754527     Document Type: Article

References (25)

1. Hanahan D,Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011Mar;144:646-674
2. Morgenstern D, Anderson J. The immune response in paediatric cancer. Open Pathology J 2010;4:45-59
3. Vakkila J, Jaffe R, Michelow M, Lotze MT. Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: A major nosologic difference with adult tumors. Clin Cancer Res 2006 Apr 1;12(7):2049-2054
4. Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008 Oct;18(5):349-355
5. Song L, Asgharzadeh S, Salo J, et al. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-Associatedmacrophages. J Clin Invest 2009 Jun;119(6):1524-1536
6. Gabrilovich DI,Nagaraj S.Myeloid-derived suppressor cells as regulators of theimmune system.Nat Rev Immunol 2009Mar;9(3):162-174
7. Martin RF, Beckwith JB. Lymphoid infiltrates in neuroblastomas: Their occurrence and prognostic significance. J Pediatr Surg 1968 Feb;3(1):161-164
8. Coughlin CM, Fleming MD, Carroll RG, et al. Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma. J Clin Oncol 2006 Dec 20;24(36):5725-5734
9. Lauder I, AherneW.The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 1972 Aug;26(4):321-330
10. Cooper R, Khakoo Y, Matthay KK, et al. Opsoclonus-myoclonus-Ataxia syndrome in neuroblastoma: Histopathologic features-A report fromthe Children's Cancer Group.Med Pediatr Oncol 2001 Jun;36(6):623-629
11. Johnson BD, Jing W, Orentas RJ. CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma. J Immunother 2007Mar;30(2):203-214
12. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer 2009 Nov;9(11):798-809
13. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007 Jan;7(1):41-51
14. Zeng M, Cui Y, Wu C. Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma. Lin Chung Er Bi Yan Hou Tou JingWai Ke Za Zhi. 2010 Aug;24(15):690-692
15. Cattaneo E,Magrassi L, De-Fraja C, et al. Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res 1998 Aug;18(4A):2381-2387
16. Schaefer LK, Ren Z, Fuller GN, Schaefer TS. Constitutive activation of Stat3alpha in brain tumors: Localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 2002Mar 27;21(13):2058-2065
17. Chen C-L, Loy A, Cen L, et al. Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMCCancer 2007;7:111
18. Niu ZBZ-B,WangCL,Hou Y, Yang Y, et al. Expression of stat3, HIF1alpha andVEGFin Wilms' Tumor. Chinese J Contempor Pediatr 2007;9(5):461-464
19. Behjati S, Basu BP,Wallace R, et al. STAT3 Regulates Proliferation and Immunogenicity of the ewing family of tumors In Vitro. Sarcoma 2012;2012:1-6
20. Morgenstern DA,Hasan F,Gibson S, et al. PAX5 expression in nonhematopoietic tissues.Reappraisal of previous studies. Am J Clin Pathol 2010Mar;133(3):407-415
21. Denkert C, Loibl S, Noske A, et al. Tumor-Associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. JCO 2010 Jan 1;28(1):105-113
22. Rahir G, Moser M. Tumor microenvironment and lymphocyte infiltration. Cancer Immunol, Immunother: CII [Internet]. 2012 Jun;61(6):751-759
23. Oble DA, Loewe R, Yu P, Mihm Jr. MC. Focus on TILS: Prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immunity 2009;9:3
24. Shablak A,Hawkins RE, Rothwell DG, Elkord E. T cell-based immunotherapy of metastatic renal cell carcinoma: Modest success and future perspective. Clin. Cancer Res. 2009 Nov 1;15(21):6503-6510
25. Nabarro S, Himoudi N, Papanastasiou A, et al. Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. J Exp Med 2005 Nov 21;202(10):1399-1410